1 Market Overview

1.1 Product Overview and Scope of Type 2 Diabetes Medication

1.2 Classification of Type 2 Diabetes Medication by Type

1.2.1 Overview: Global Type 2 Diabetes Medication Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Type 2 Diabetes Medication Revenue Market Share by Type in 2021

1.2.3 Biguanides

1.2.4 Sulphonylureas

1.2.5 Thiazolidinediones

1.2.6 Alpha-glucosidase Inhibitors

1.2.7 DPP-4 Inhibitors

1.2.8 GLP-1 Receptor Agonists

1.2.9 SGLT-2 Inhibitors

1.2.10 Insulins

1.3 Global Type 2 Diabetes Medication Market by Application

1.3.1 Overview: Global Type 2 Diabetes Medication Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Hospital Pharmacies

1.3.3 Retail Pharmacies

1.3.4 Online Pharmacies

1.4 Global Type 2 Diabetes Medication Market Size & Forecast

1.5 Global Type 2 Diabetes Medication Market Size and Forecast by Region

1.5.1 Global Type 2 Diabetes Medication Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Type 2 Diabetes Medication Market Size by Region, (2017-2022)

1.5.3 North America Type 2 Diabetes Medication Market Size and Prospect (2017-2028)

1.5.4 Europe Type 2 Diabetes Medication Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Type 2 Diabetes Medication Market Size and Prospect (2017-2028)

1.5.6 South America Type 2 Diabetes Medication Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Type 2 Diabetes Medication Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Type 2 Diabetes Medication Market Drivers

1.6.2 Type 2 Diabetes Medication Market Restraints

1.6.3 Type 2 Diabetes Medication Trends Analysis

2 Company Profiles

2.1 AstraZeneca

2.1.1 AstraZeneca Details

2.1.2 AstraZeneca Major Business

2.1.3 AstraZeneca Type 2 Diabetes Medication Product and Solutions

2.1.4 AstraZeneca Type 2 Diabetes Medication Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 AstraZeneca Recent Developments and Future Plans

2.2 Novartis

2.2.1 Novartis Details

2.2.2 Novartis Major Business

2.2.3 Novartis Type 2 Diabetes Medication Product and Solutions

2.2.4 Novartis Type 2 Diabetes Medication Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 Novartis Recent Developments and Future Plans

2.3 Novo Nordisk

2.3.1 Novo Nordisk Details

2.3.2 Novo Nordisk Major Business

2.3.3 Novo Nordisk Type 2 Diabetes Medication Product and Solutions

2.3.4 Novo Nordisk Type 2 Diabetes Medication Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 Novo Nordisk Recent Developments and Future Plans

2.4 Johnson & Johnson

2.4.1 Johnson & Johnson Details

2.4.2 Johnson & Johnson Major Business

2.4.3 Johnson & Johnson Type 2 Diabetes Medication Product and Solutions

2.4.4 Johnson & Johnson Type 2 Diabetes Medication Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 Johnson & Johnson Recent Developments and Future Plans

2.5 Boehringer Ingelheim

2.5.1 Boehringer Ingelheim Details

2.5.2 Boehringer Ingelheim Major Business

2.5.3 Boehringer Ingelheim Type 2 Diabetes Medication Product and Solutions

2.5.4 Boehringer Ingelheim Type 2 Diabetes Medication Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 Boehringer Ingelheim Recent Developments and Future Plans

2.6 Bristol-Myers Squibb

2.6.1 Bristol-Myers Squibb Details

2.6.2 Bristol-Myers Squibb Major Business

2.6.3 Bristol-Myers Squibb Type 2 Diabetes Medication Product and Solutions

2.6.4 Bristol-Myers Squibb Type 2 Diabetes Medication Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 Bristol-Myers Squibb Recent Developments and Future Plans

2.7 Eli Lilly

2.7.1 Eli Lilly Details

2.7.2 Eli Lilly Major Business

2.7.3 Eli Lilly Type 2 Diabetes Medication Product and Solutions

2.7.4 Eli Lilly Type 2 Diabetes Medication Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 Eli Lilly Recent Developments and Future Plans

2.8 Merck

2.8.1 Merck Details

2.8.2 Merck Major Business

2.8.3 Merck Type 2 Diabetes Medication Product and Solutions

2.8.4 Merck Type 2 Diabetes Medication Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 Merck Recent Developments and Future Plans

2.9 Sanofi

2.9.1 Sanofi Details

2.9.2 Sanofi Major Business

2.9.3 Sanofi Type 2 Diabetes Medication Product and Solutions

2.9.4 Sanofi Type 2 Diabetes Medication Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 Sanofi Recent Developments and Future Plans

2.10 Pfizer

2.10.1 Pfizer Details

2.10.2 Pfizer Major Business

2.10.3 Pfizer Type 2 Diabetes Medication Product and Solutions

2.10.4 Pfizer Type 2 Diabetes Medication Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10.5 Pfizer Recent Developments and Future Plans

2.11 Astellas Pharma

2.11.1 Astellas Pharma Details

2.11.2 Astellas Pharma Major Business

2.11.3 Astellas Pharma Type 2 Diabetes Medication Product and Solutions

2.11.4 Astellas Pharma Type 2 Diabetes Medication Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.11.5 Astellas Pharma Recent Developments and Future Plans

2.12 Daiichi Sankyo

2.12.1 Daiichi Sankyo Details

2.12.2 Daiichi Sankyo Major Business

2.12.3 Daiichi Sankyo Type 2 Diabetes Medication Product and Solutions

2.12.4 Daiichi Sankyo Type 2 Diabetes Medication Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.12.5 Daiichi Sankyo Recent Developments and Future Plans

2.13 Biocon

2.13.1 Biocon Details

2.13.2 Biocon Major Business

2.13.3 Biocon Type 2 Diabetes Medication Product and Solutions

2.13.4 Biocon Type 2 Diabetes Medication Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.13.5 Biocon Recent Developments and Future Plans

2.14 Glenmark

2.14.1 Glenmark Details

2.14.2 Glenmark Major Business

2.14.3 Glenmark Type 2 Diabetes Medication Product and Solutions

2.14.4 Glenmark Type 2 Diabetes Medication Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.14.5 Glenmark Recent Developments and Future Plans

2.15 Bayer AG

2.15.1 Bayer AG Details

2.15.2 Bayer AG Major Business

2.15.3 Bayer AG Type 2 Diabetes Medication Product and Solutions

2.15.4 Bayer AG Type 2 Diabetes Medication Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.15.5 Bayer AG Recent Developments and Future Plans

2.16 Takeda

2.16.1 Takeda Details

2.16.2 Takeda Major Business

2.16.3 Takeda Type 2 Diabetes Medication Product and Solutions

2.16.4 Takeda Type 2 Diabetes Medication Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.16.5 Takeda Recent Developments and Future Plans

2.17 Sun pharma

2.17.1 Sun pharma Details

2.17.2 Sun pharma Major Business

2.17.3 Sun pharma Type 2 Diabetes Medication Product and Solutions

2.17.4 Sun pharma Type 2 Diabetes Medication Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.17.5 Sun pharma Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Type 2 Diabetes Medication Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Type 2 Diabetes Medication Players Market Share in 2021

3.2.2 Top 10 Type 2 Diabetes Medication Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Type 2 Diabetes Medication Players Head Office, Products and Services Provided

3.4 Type 2 Diabetes Medication Mergers & Acquisitions

3.5 Type 2 Diabetes Medication New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Type 2 Diabetes Medication Revenue and Market Share by Type (2017-2022)

4.2 Global Type 2 Diabetes Medication Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5.1 Global Type 2 Diabetes Medication Revenue Market Share by Application (2017-2022)

5.2 Global Type 2 Diabetes Medication Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6.1 North America Type 2 Diabetes Medication Revenue by Type (2017-2028)

6.2 North America Type 2 Diabetes Medication Revenue by Application (2017-2028)

6.3 North America Type 2 Diabetes Medication Market Size by Country

6.3.1 North America Type 2 Diabetes Medication Revenue by Country (2017-2028)

6.3.2 United States Type 2 Diabetes Medication Market Size and Forecast (2017-2028)

6.3.3 Canada Type 2 Diabetes Medication Market Size and Forecast (2017-2028)

6.3.4 Mexico Type 2 Diabetes Medication Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7.1 Europe Type 2 Diabetes Medication Revenue by Type (2017-2028)

7.2 Europe Type 2 Diabetes Medication Revenue by Application (2017-2028)

7.3 Europe Type 2 Diabetes Medication Market Size by Country

7.3.1 Europe Type 2 Diabetes Medication Revenue by Country (2017-2028)

7.3.2 Germany Type 2 Diabetes Medication Market Size and Forecast (2017-2028)

7.3.3 France Type 2 Diabetes Medication Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Type 2 Diabetes Medication Market Size and Forecast (2017-2028)

7.3.5 Russia Type 2 Diabetes Medication Market Size and Forecast (2017-2028)

7.3.6 Italy Type 2 Diabetes Medication Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Type 2 Diabetes Medication Revenue by Type (2017-2028)

8.2 Asia-Pacific Type 2 Diabetes Medication Revenue by Application (2017-2028)

8.3 Asia-Pacific Type 2 Diabetes Medication Market Size by Region

8.3.1 Asia-Pacific Type 2 Diabetes Medication Revenue by Region (2017-2028)

8.3.2 China Type 2 Diabetes Medication Market Size and Forecast (2017-2028)

8.3.3 Japan Type 2 Diabetes Medication Market Size and Forecast (2017-2028)

8.3.4 South Korea Type 2 Diabetes Medication Market Size and Forecast (2017-2028)

8.3.5 India Type 2 Diabetes Medication Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Type 2 Diabetes Medication Market Size and Forecast (2017-2028)

8.3.7 Australia Type 2 Diabetes Medication Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9.1 South America Type 2 Diabetes Medication Revenue by Type (2017-2028)

9.2 South America Type 2 Diabetes Medication Revenue by Application (2017-2028)

9.3 South America Type 2 Diabetes Medication Market Size by Country

9.3.1 South America Type 2 Diabetes Medication Revenue by Country (2017-2028)

9.3.2 Brazil Type 2 Diabetes Medication Market Size and Forecast (2017-2028)

9.3.3 Argentina Type 2 Diabetes Medication Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Type 2 Diabetes Medication Revenue by Type (2017-2028)

10.2 Middle East & Africa Type 2 Diabetes Medication Revenue by Application (2017-2028)

10.3 Middle East & Africa Type 2 Diabetes Medication Market Size by Country

10.3.1 Middle East & Africa Type 2 Diabetes Medication Revenue by Country (2017-2028)

10.3.2 Turkey Type 2 Diabetes Medication Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Type 2 Diabetes Medication Market Size and Forecast (2017-2028)

10.3.4 UAE Type 2 Diabetes Medication Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Type 2 Diabetes Medication Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Type 2 Diabetes Medication Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Type 2 Diabetes Medication Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Type 2 Diabetes Medication Revenue (USD Million) by Region (2017-2022)

Table 5. Global Type 2 Diabetes Medication Revenue Market Share by Region (2023-2028)

Table 6. AstraZeneca Corporate Information, Head Office, and Major Competitors

Table 7. AstraZeneca Major Business

Table 8. AstraZeneca Type 2 Diabetes Medication Product and Solutions

Table 9. AstraZeneca Type 2 Diabetes Medication Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. Novartis Corporate Information, Head Office, and Major Competitors

Table 11. Novartis Major Business

Table 12. Novartis Type 2 Diabetes Medication Product and Solutions

Table 13. Novartis Type 2 Diabetes Medication Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. Novo Nordisk Corporate Information, Head Office, and Major Competitors

Table 15. Novo Nordisk Major Business

Table 16. Novo Nordisk Type 2 Diabetes Medication Product and Solutions

Table 17. Novo Nordisk Type 2 Diabetes Medication Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. Johnson & Johnson Corporate Information, Head Office, and Major Competitors

Table 19. Johnson & Johnson Major Business

Table 20. Johnson & Johnson Type 2 Diabetes Medication Product and Solutions

Table 21. Johnson & Johnson Type 2 Diabetes Medication Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. Boehringer Ingelheim Corporate Information, Head Office, and Major Competitors

Table 23. Boehringer Ingelheim Major Business

Table 24. Boehringer Ingelheim Type 2 Diabetes Medication Product and Solutions

Table 25. Boehringer Ingelheim Type 2 Diabetes Medication Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. Bristol-Myers Squibb Corporate Information, Head Office, and Major Competitors

Table 27. Bristol-Myers Squibb Major Business

Table 28. Bristol-Myers Squibb Type 2 Diabetes Medication Product and Solutions

Table 29. Bristol-Myers Squibb Type 2 Diabetes Medication Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. Eli Lilly Corporate Information, Head Office, and Major Competitors

Table 31. Eli Lilly Major Business

Table 32. Eli Lilly Type 2 Diabetes Medication Product and Solutions

Table 33. Eli Lilly Type 2 Diabetes Medication Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. Merck Corporate Information, Head Office, and Major Competitors

Table 35. Merck Major Business

Table 36. Merck Type 2 Diabetes Medication Product and Solutions

Table 37. Merck Type 2 Diabetes Medication Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. Sanofi Corporate Information, Head Office, and Major Competitors

Table 39. Sanofi Major Business

Table 40. Sanofi Type 2 Diabetes Medication Product and Solutions

Table 41. Sanofi Type 2 Diabetes Medication Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. Pfizer Corporate Information, Head Office, and Major Competitors

Table 43. Pfizer Major Business

Table 44. Pfizer Type 2 Diabetes Medication Product and Solutions

Table 45. Pfizer Type 2 Diabetes Medication Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 46. Astellas Pharma Corporate Information, Head Office, and Major Competitors

Table 47. Astellas Pharma Major Business

Table 48. Astellas Pharma Type 2 Diabetes Medication Product and Solutions

Table 49. Astellas Pharma Type 2 Diabetes Medication Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 50. Daiichi Sankyo Corporate Information, Head Office, and Major Competitors

Table 51. Daiichi Sankyo Major Business

Table 52. Daiichi Sankyo Type 2 Diabetes Medication Product and Solutions

Table 53. Daiichi Sankyo Type 2 Diabetes Medication Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 54. Biocon Corporate Information, Head Office, and Major Competitors

Table 55. Biocon Major Business

Table 56. Biocon Type 2 Diabetes Medication Product and Solutions

Table 57. Biocon Type 2 Diabetes Medication Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 58. Glenmark Corporate Information, Head Office, and Major Competitors

Table 59. Glenmark Major Business

Table 60. Glenmark Type 2 Diabetes Medication Product and Solutions

Table 61. Glenmark Type 2 Diabetes Medication Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 62. Bayer AG Corporate Information, Head Office, and Major Competitors

Table 63. Bayer AG Major Business

Table 64. Bayer AG Type 2 Diabetes Medication Product and Solutions

Table 65. Bayer AG Type 2 Diabetes Medication Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 66. Takeda Corporate Information, Head Office, and Major Competitors

Table 67. Takeda Major Business

Table 68. Takeda Type 2 Diabetes Medication Product and Solutions

Table 69. Takeda Type 2 Diabetes Medication Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 70. Sun pharma Corporate Information, Head Office, and Major Competitors

Table 71. Sun pharma Major Business

Table 72. Sun pharma Type 2 Diabetes Medication Product and Solutions

Table 73. Sun pharma Type 2 Diabetes Medication Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 74. Global Type 2 Diabetes Medication Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 75. Global Type 2 Diabetes Medication Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 76. Breakdown of Type 2 Diabetes Medication by Company Type (Tier 1, Tier 2 and Tier 3)

Table 77. Type 2 Diabetes Medication Players Head Office, Products and Services Provided

Table 78. Type 2 Diabetes Medication Mergers & Acquisitions in the Past Five Years

Table 79. Type 2 Diabetes Medication New Entrants and Expansion Plans

Table 80. Global Type 2 Diabetes Medication Revenue (USD Million) by Type (2017-2022)

Table 81. Global Type 2 Diabetes Medication Revenue Share by Type (2017-2022)

Table 82. Global Type 2 Diabetes Medication Revenue Forecast by Type (2023-2028)

Table 83. Global Type 2 Diabetes Medication Revenue by Application (2017-2022)

Table 84. Global Type 2 Diabetes Medication Revenue Forecast by Application (2023-2028)

Table 85. North America Type 2 Diabetes Medication Revenue by Type (2017-2022) & (USD Million)

Table 86. North America Type 2 Diabetes Medication Revenue by Type (2023-2028) & (USD Million)

Table 87. North America Type 2 Diabetes Medication Revenue by Application (2017-2022) & (USD Million)

Table 88. North America Type 2 Diabetes Medication Revenue by Application (2023-2028) & (USD Million)

Table 89. North America Type 2 Diabetes Medication Revenue by Country (2017-2022) & (USD Million)

Table 90. North America Type 2 Diabetes Medication Revenue by Country (2023-2028) & (USD Million)

Table 91. Europe Type 2 Diabetes Medication Revenue by Type (2017-2022) & (USD Million)

Table 92. Europe Type 2 Diabetes Medication Revenue by Type (2023-2028) & (USD Million)

Table 93. Europe Type 2 Diabetes Medication Revenue by Application (2017-2022) & (USD Million)

Table 94. Europe Type 2 Diabetes Medication Revenue by Application (2023-2028) & (USD Million)

Table 95. Europe Type 2 Diabetes Medication Revenue by Country (2017-2022) & (USD Million)

Table 96. Europe Type 2 Diabetes Medication Revenue by Country (2023-2028) & (USD Million)

Table 97. Asia-Pacific Type 2 Diabetes Medication Revenue by Type (2017-2022) & (USD Million)

Table 98. Asia-Pacific Type 2 Diabetes Medication Revenue by Type (2023-2028) & (USD Million)

Table 99. Asia-Pacific Type 2 Diabetes Medication Revenue by Application (2017-2022) & (USD Million)

Table 100. Asia-Pacific Type 2 Diabetes Medication Revenue by Application (2023-2028) & (USD Million)

Table 101. Asia-Pacific Type 2 Diabetes Medication Revenue by Region (2017-2022) & (USD Million)

Table 102. Asia-Pacific Type 2 Diabetes Medication Revenue by Region (2023-2028) & (USD Million)

Table 103. South America Type 2 Diabetes Medication Revenue by Type (2017-2022) & (USD Million)

Table 104. South America Type 2 Diabetes Medication Revenue by Type (2023-2028) & (USD Million)

Table 105. South America Type 2 Diabetes Medication Revenue by Application (2017-2022) & (USD Million)

Table 106. South America Type 2 Diabetes Medication Revenue by Application (2023-2028) & (USD Million)

Table 107. South America Type 2 Diabetes Medication Revenue by Country (2017-2022) & (USD Million)

Table 108. South America Type 2 Diabetes Medication Revenue by Country (2023-2028) & (USD Million)

Table 109. Middle East & Africa Type 2 Diabetes Medication Revenue by Type (2017-2022) & (USD Million)

Table 110. Middle East & Africa Type 2 Diabetes Medication Revenue by Type (2023-2028) & (USD Million)

Table 111. Middle East & Africa Type 2 Diabetes Medication Revenue by Application (2017-2022) & (USD Million)

Table 112. Middle East & Africa Type 2 Diabetes Medication Revenue by Application (2023-2028) & (USD Million)

Table 113. Middle East & Africa Type 2 Diabetes Medication Revenue by Country (2017-2022) & (USD Million)

Table 114. Middle East & Africa Type 2 Diabetes Medication Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Type 2 Diabetes Medication Picture

Figure 2. Global Type 2 Diabetes Medication Revenue Market Share by Type in 2021

Figure 3. Biguanides

Figure 4. Sulphonylureas

Figure 5. Thiazolidinediones

Figure 6. Alpha-glucosidase Inhibitors

Figure 7. DPP-4 Inhibitors

Figure 8. GLP-1 Receptor Agonists

Figure 9. SGLT-2 Inhibitors

Figure 10. Insulins

Figure 11. Type 2 Diabetes Medication Revenue Market Share by Application in 2021

Figure 12. Hospital Pharmacies Picture

Figure 13. Retail Pharmacies Picture

Figure 14. Online Pharmacies Picture

Figure 15. Global Type 2 Diabetes Medication Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 16. Global Type 2 Diabetes Medication Revenue and Forecast (2017-2028) & (USD Million)

Figure 17. Global Type 2 Diabetes Medication Revenue Market Share by Region (2017-2028)

Figure 18. Global Type 2 Diabetes Medication Revenue Market Share by Region in 2021

Figure 19. North America Type 2 Diabetes Medication Revenue (USD Million) and Growth Rate (2017-2028)

Figure 20. Europe Type 2 Diabetes Medication Revenue (USD Million) and Growth Rate (2017-2028)

Figure 21. Asia-Pacific Type 2 Diabetes Medication Revenue (USD Million) and Growth Rate (2017-2028)

Figure 22. South America Type 2 Diabetes Medication Revenue (USD Million) and Growth Rate (2017-2028)

Figure 23. Middle East and Africa Type 2 Diabetes Medication Revenue (USD Million) and Growth Rate (2017-2028)

Figure 24. Type 2 Diabetes Medication Market Drivers

Figure 25. Type 2 Diabetes Medication Market Restraints

Figure 26. Type 2 Diabetes Medication Market Trends

Figure 27. AstraZeneca Recent Developments and Future Plans

Figure 28. Novartis Recent Developments and Future Plans

Figure 29. Novo Nordisk Recent Developments and Future Plans

Figure 30. Johnson & Johnson Recent Developments and Future Plans

Figure 31. Boehringer Ingelheim Recent Developments and Future Plans

Figure 32. Bristol-Myers Squibb Recent Developments and Future Plans

Figure 33. Eli Lilly Recent Developments and Future Plans

Figure 34. Merck Recent Developments and Future Plans

Figure 35. Sanofi Recent Developments and Future Plans

Figure 36. Pfizer Recent Developments and Future Plans

Figure 37. Astellas Pharma Recent Developments and Future Plans

Figure 38. Daiichi Sankyo Recent Developments and Future Plans

Figure 39. Biocon Recent Developments and Future Plans

Figure 40. Glenmark Recent Developments and Future Plans

Figure 41. Bayer AG Recent Developments and Future Plans

Figure 42. Takeda Recent Developments and Future Plans

Figure 43. Sun pharma Recent Developments and Future Plans

Figure 44. Global Type 2 Diabetes Medication Revenue Share by Players in 2021

Figure 45. Type 2 Diabetes Medication Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 46. Global Top 3 Players Type 2 Diabetes Medication Revenue Market Share in 2021

Figure 47. Global Top 10 Players Type 2 Diabetes Medication Revenue Market Share in 2021

Figure 48. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 49. Global Type 2 Diabetes Medication Revenue Share by Type in 2021

Figure 50. Global Type 2 Diabetes Medication Market Share Forecast by Type (2023-2028)

Figure 51. Global Type 2 Diabetes Medication Revenue Share by Application in 2021

Figure 52. Global Type 2 Diabetes Medication Market Share Forecast by Application (2023-2028)

Figure 53. North America Type 2 Diabetes Medication Sales Market Share by Type (2017-2028)

Figure 54. North America Type 2 Diabetes Medication Sales Market Share by Application (2017-2028)

Figure 55. North America Type 2 Diabetes Medication Revenue Market Share by Country (2017-2028)

Figure 56. United States Type 2 Diabetes Medication Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 57. Canada Type 2 Diabetes Medication Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 58. Mexico Type 2 Diabetes Medication Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 59. Europe Type 2 Diabetes Medication Sales Market Share by Type (2017-2028)

Figure 60. Europe Type 2 Diabetes Medication Sales Market Share by Application (2017-2028)

Figure 61. Europe Type 2 Diabetes Medication Revenue Market Share by Country (2017-2028)

Figure 62. Germany Type 2 Diabetes Medication Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 63. France Type 2 Diabetes Medication Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 64. United Kingdom Type 2 Diabetes Medication Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 65. Russia Type 2 Diabetes Medication Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 66. Italy Type 2 Diabetes Medication Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 67. Asia-Pacific Type 2 Diabetes Medication Sales Market Share by Type (2017-2028)

Figure 68. Asia-Pacific Type 2 Diabetes Medication Sales Market Share by Application (2017-2028)

Figure 69. Asia-Pacific Type 2 Diabetes Medication Revenue Market Share by Region (2017-2028)

Figure 70. China Type 2 Diabetes Medication Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 71. Japan Type 2 Diabetes Medication Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 72. South Korea Type 2 Diabetes Medication Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 73. India Type 2 Diabetes Medication Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 74. Southeast Asia Type 2 Diabetes Medication Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 75. Australia Type 2 Diabetes Medication Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 76. South America Type 2 Diabetes Medication Sales Market Share by Type (2017-2028)

Figure 77. South America Type 2 Diabetes Medication Sales Market Share by Application (2017-2028)

Figure 78. South America Type 2 Diabetes Medication Revenue Market Share by Country (2017-2028)

Figure 79. Brazil Type 2 Diabetes Medication Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 80. Argentina Type 2 Diabetes Medication Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 81. Middle East and Africa Type 2 Diabetes Medication Sales Market Share by Type (2017-2028)

Figure 82. Middle East and Africa Type 2 Diabetes Medication Sales Market Share by Application (2017-2028)

Figure 83. Middle East and Africa Type 2 Diabetes Medication Revenue Market Share by Country (2017-2028)

Figure 84. Turkey Type 2 Diabetes Medication Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 85. Saudi Arabia Type 2 Diabetes Medication Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 86. UAE Type 2 Diabetes Medication Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 87. Methodology

Figure 88. Research Process and Data Source